Inovio Pharmaceuticals
INO
#8866
Rank
โ‚น13.35 B
Marketcap
โ‚น194.45
Share price
-0.69%
Change (1 day)
-43.15%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น6.95 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are โ‚น6.95 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น3.83 B-14.08%
2023-12-31โ‚น4.46 B-57.26%
2022-12-31โ‚น10.44 B45.7%
2021-12-31โ‚น7.16 B24.61%
2020-12-31โ‚น5.75 B-41.79%
2019-12-31โ‚น9.87 B220.54%
2018-12-31โ‚น3.08 B7.87%
2017-12-31โ‚น2.85 B-16.45%
2016-12-31โ‚น3.42 B35.76%
2015-12-31โ‚น2.51 B96.31%
2014-12-31โ‚น1.28 B-41.3%
2013-12-31โ‚น2.18 B288.33%
2012-12-31โ‚น0.56 B-19.66%
2011-12-31โ‚น0.70 B74.38%
2010-12-31โ‚น0.40 B-55.47%
2009-12-31โ‚น0.90 B-5.59%
2008-12-31โ‚น0.95 B178.58%
2007-12-31โ‚น0.34 B-37.78%
2006-12-31โ‚น0.55 B122.42%
2005-12-31โ‚น0.24 B5.95%
2004-12-31โ‚น0.23 B334.95%
2003-12-31โ‚น53.78 M-33.78%
2002-12-31โ‚น81.22 M0.77%
2001-12-31โ‚น80.6 M
2001-03-31โ‚น74.43 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚น10.433 T 149,869.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น10.244 T 147,151.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น77.67 B 1,016.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.642 T 81,005.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น7.005 T 100,591.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น5.529 T 79,381.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
โ‚น3.345 T 47,986.00%๐Ÿ‡บ๐Ÿ‡ธ USA